Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of 2026 Annual Meeting

3rd Aug 2026 15:02

RNS Number : 0638P
MyCelx Technologies Corporation
03 August 2026
 

3 August 2026

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Mailing of Notice of 2026 Annual Meeting

 

MYCELX Technologies Corporation (AIM: MYX), a leading provider of proprietary water treatment technology to the Oil and Gas and other industries worldwide, announces that, following the mailing to shareholders on 16 June 2026 of the Company's 2025 Annual Report, the Notice of 2026 Annual Meeting is today being mailed to shareholders.

 

Copies have been placed on the Company's website at www.mycelx.com. Copies will also be available free of charge from the Company's headquarters at 1650 International Court, Suite 100, Norcross, Georgia, USA 30093 for a period of at least one month.

 

Annual Meeting

 

As previously announced, the Company's 2026 Annual Meeting will be held at 2:00 p.m. (BST) on Thursday 17 September 2026 at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London, EC1A 7BL.

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance)

Harriet Ward (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

 

Tel: +44 20 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAKZGGRFFRGVZM

Related Shares:

Mycelx Di
FTSE 100 Latest
Value10,888.71
Change31.01